Skip to main content

Treating Adolescents and Young Adults with Blood Cancer

Recorded on May 13, 2021

Click Here to Participate 

Format: Noninteractive recorded webinar
1.0 CME/CE Credit Available Until: 
December 16, 2022


Target Audience

Physicians, advance practice providers, and nurses involved in the care of adolescents and young adults with hematologic malignancies.

Learning Objectives

After completing this activity, participants should be better able to:

  • Describe common adolescent and young adult (AYA) blood cancers
  • Identify signs and symptoms of AYA blood cancer and diagnostic tests
  • Explain treatments, including the role of clinical trials
  • Discuss management of short and long-term effects, including fertility challenges
  • Address unique considerations for AYA's (e.g., sexuality and intimacy, finances and health insurance)
  • Discuss strategies to enhance provider communication with AYA's to help them navigate challenges



Leidy L. Isenalumhe, MD, MS
Assistant Member, Malignant Hematology
Director of Clinical Operations, Malignant Hematology
H. Lee Moffitt Cancer Center and Research Institute
Tampa, FL


Continuing Medical Education and Continuing Education Information

Physician Credit Designation
The Treating Adolescents and Young Adults with Blood Cancer program is approved for up to 1.0 prescribed credit by the American Academy of Family Physicians (AAFP). Please complete the evaluation to obtain enduring CME credit.

Registered Nursing Credit Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.

All continuing education credits are provided free of charge.

Participants must attend the webinar in its entirety, submit the online evaluation form and successfully complete the post-test to earn credit. Once submitted, the certificate will be generated as a PDF online.

There are no system requirements other than an internet connection.



This program is sponsored by The Leukemia & Lymphoma Society and Clinical Directors Network, Inc. 

For questions, concerns, or for assistance for people with disabilities or grievances, please contact


< Back to Continuing Education